Effects of losartan versus captopril on mortality in patients with symptomatic heart failure: Rationale, design, and baseline characteristics of patients in the losartan heart failure survival study-ELITE II

This publication has 14 references indexed in Scilit:

• Effects of Angiotensin II Antagonists in Comparison to ACE Inhibitors in Patients with Heart Failure due to Systolic Left Ventricular Dysfunction
  Heart Failure Reviews, 1999
• Experimental evidence to support ELITE
  The Lancet, 1998
• Primary Prevention of Sudden Cardiac Death in Heart Failure: Will the Solution Be Shocking?
  Journal of the American College of Cardiology, 1997
• Reasons for Underuse of Angiotensin-Converting Enzyme Inhibitors in Patients With Heart Failure and Left Ventricular Dysfunction
  The American Journal of Cardiology, 1997
• Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)
  Published by Elsevier ,1997
• Prognostic Significance of Plasma Norepinephrine in Patients With Asymptomatic Left Ventricular Dysfunction
  Circulation, 1996
• Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction
  The Lancet, 1996
• Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials
  JAMA, 1995
• Antiarrhythmic effects of ACE inhibitors: a matter of faith or reality?
  Cardiovascular Research, 1994
• Comparison of Captopril and Enalapril in Patients with Severe Chronic Heart Failure
  New England Journal of Medicine, 1986